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Abstract 
Lifestyle (smoking, drinking alcohol) and body mass index (BMI) predictors of 
successful outcomes in assisted reproductive technology (ART) treatments were 
examined in this meta-analysis. Method: A bibliographic search was undertaken 
using 6 databases. The review was informed by PRISMA/MOOSE guidelines. Meta-
analytic data were analysed using random effects models.  Results: We included 77 
studies examining effects of BMI, smoking and drinking alcohol. Patients with a BMI 
<=24.9 were significantly more likely to achieve LB/pregnancy than with BMI >=25 
OR=1.219 (95% CI:1.128-1.319, z=4.971, p<001; I2=53.779%, p=0.001). Non-
smokers were significantly more likely to achieve a LB or pregnancy than smokers 
OR=1.457 (95% CI:1.228-1.727, z=4.324, p< 0.001; I2=51.883; p=0.001). Meta-
regression revealed the number of embryos transferred significantly moderated the 
effects of smoking on ART outcomes, and there was a trend indicating primary 
infertility and high BMI were also significant moderators.  The evidence for drinking 
alcohol was inconclusive due to the small number of studies. Conclusion: This 
meta-analysis confirms that ART treatment success can be predicted with lifestyle 
factors. Further, non-smokers’ relative odds of pregnancy/live birth increase as more 
embryos were transferred but there was a trend that the odds of pregnancy/live birth 
decrease with primary infertility and high BMI.  
 
 
 
 
 
 
Introduction 
It is estimated that one in six couples will experience infertility, which is defined as a 
failure to achieve pregnancy after regular sex for 1 year, and increasingly couples 
are seeking assisted reproductive technology (ART) [1]. Success rates of a single 
cycle of ART vary worldwide, with US and UK clinics reporting some of the highest 
rates between 2012–2013 (29% and 26% respectively), and Japan reporting the 
lowest (5%) [2]. Women who undertake ART often report ‘unhealthy lifestyles’. For 
example, Domar et al [3] . found that during their IVF treatment, just under 50% of 
women drank alcohol and 2% reported smoking. Whereas, another recent study [4] 
also found  high rates of alcohol consumption (50.8%) and  less than half of women 
who consumed alcohol regularly reduced their intake and 60% did not reduce 
consumption of caffeinated drinks. Further, the majority did not change their BMI 
(83.6%) ahead of fertility treatment.  
 
Research on the effect of lifestyle variables such as obesity, smoking and alcohol 
consumption on assisted reproductive technologies (ART) outcomes has often been 
inconsistent. Narrative reviews have reported a negative impact of maternal obesity 
on ART outcomes [5-6] and positive effects of weight loss on improving ART 
pregnancy rates [7], and these have been supported by systematic reviews/meta-
analytic evidence [8]. Other meta-analytic reviews [9] reported small effects for BMI 
on ART outcome, or insufficient evidence to support the link between high BMI and 
lower birth rates, [10], and no associations between obesity and chance of 
pregnancy after IVF using donor oocytes [11]. 
 
 
 
Unlike obesity, smoking has much more consistently been found to be detrimental to 
reproductive health and fertility outcomes [12]. However, the evidence synthesis on 
the effects of smoking is out-dated [13-15] with some recent empirical evidence 
demonstrating no effects of maternal and paternal smoking on IVF outcomes [16]. 
The effects of alcohol on fertility and fertility treatment is inconclusive [17-18], 
although a review of 2 studies demonstrated decreased pregnancy rates for couples 
who drank alcohol before or during their treatment [19].  
 
It is possible that one of the reasons for these inconsistencies reported in systematic 
reviews and meta-analysis on lifestyle data is due to the fact that most previous 
research, has only examined if BMI and lifestyle factors (including smoking and 
alcohol consumption) directly predict ART outcomes, without sufficient investigation 
into whether they also act as moderators for each other on ART outcomes. This is 
important because these BMI and lifestyles behaviours are often comorbid, although 
the relationship is complex. For example, a study of 499,504 adults (31 to 69 years) 
[20] found current smokers were less likely to be obese than never smokers but 
former smokers were more likely to be obese than current smokers. Further, the risk 
of obesity increased with the number of cigarettes smoked and decreased from 
quitting. However, there is a clear association between increased amount of alcohol 
drank and increased risk of obesity [21].  
 
The objectives of this meta-analysis were therefore to reconcile previous research 
and examine: a) whether lifestyle factors predict ART treatment success for female 
patients; and b) whether lifestyle and BMI factors moderate each other. 
 
 
 
Methods 
 
Search strategy 
This systematic review and meta-analysis was organised and structured according to 
PRISMA and MOOSE guidelines [22]. A bibliographic search evaluating lifestyle 
predictors of IVF outcomes (pregnancy or live birth) was undertaken using PubMed, 
PsycInfo, Embase, ScienceDirect, Web of Science and Scopus. The search was last 
updated in November 2016. In PubMed, the search terms in titles and abstracts 
were: (“IVF” OR “intracytoplasmic” OR “intracytoplasmic sperm injection” OR “in vitro 
fertilization” OR “ICSI” OR “assisted reproductive technology” OR “in vitro 
fertilisation”) AND (“BMI” OR “body mass index” OR “smoke” OR “smoking” OR 
“alcohol” OR “drinking”) AND (“pregnancy” OR “live birth” OR “birth rates” or 
“pregnant”). The search was limited to English language journal articles published 
after 1978/01/01, concerning humans only. Similar search engine appropriate terms 
were used in the remaining databases. References cited in previous review papers 
were also hand searched [e.g., 10-11, 13-14].  
,  
Study selection 
Studies were included if they were published as peer reviewed journal articles; 
available in English; presented original data; ART treatment included IVF, ICSI, 
ZIFT, GIFT, treatments such as IUI were excluded because they are not ART. 
Prospective and retrospective designs were eligible. If it was not possible to 
calculate unadjusted effect sizes for predictor variables studies were excluded, as 
were studies of surrogates and oocyte donors/recipients. Where studies reported 
overlapping data, the study with the largest number of participants was included in 
the meta-analysis. Data from large national or worldwide databases were excluded 
 
 
because they often included oocyte donation data, often did not specify which ART 
techniques were used and posed a risk of multiple report publications.  
 
BMI studies were included if they investigated a link between women’s BMI and 
treatment outcome. It was expected that there would be some variation between 
studies on their classification of BMI groupings, although standard WHO 
classifications of BMI groups are normal weight 19-24.9 BMI; overweight 25-29.9 
BMI; and obese >30 BMI (WHO, 2006). Based upon WHO classifications, three BMI 
groups were compared: <=24.9 vs >=25 BMI; 19-24.9 BMI vs 25-29.9 BMI; and 25-
29.9 vs 30-34.9 BMI. Studies which did not match WHO criteria were included if it 
was possible to combine results into the criteria adapted to allow meaningful data 
analyses. For example, boundaries approximating WHO categories within 1 unit of 
BMI were combined within the same analyses. No significant differences in effect 
sizes were found between WHO cut-off levels (i.e., <=24.9 vs >=25 BMI) and studies 
using cut-offs within 1 unit of BMI criteria (e.g., <=24 vs >24 BMI) (Q=0.175, df, 1, 
p=0.676)  
 
Smoking studies were included if they tested for an association between female 
smoking at the time of treatment and ART outcomes. Alcohol studies were selected 
if they tested for an association between female patients’ alcohol consumption and 
ART outcome. For both lifestyles, continuous and categorical data were included.   
 
Data screening and extraction 
The first author independently screened titles, abstracts and full-text reports of all 
search results and these were cross-checked by the second author, following 
 
 
PRISMA guidelines [23]. Disagreements were resolved by discussion. The selection 
of studies was informed by the research question, inclusion/exclusion criteria, and 
full consensus by all authors. Data extracted included all independent (BMI; smoking 
and alcohol consumption) and dependent variables (live birth or pregnancy) and 
sample sizes. When two or more dependent variables were reported (e.g., serum 
pregnancy, clinical pregnancy and live birth), the data which is considered ‘gold 
standard’ was recorded (in this case, live birth) [24]. Additional data was also 
inputted, including patient characteristics (female age, average sample BMI, 
percentage of smokers in sample, number of oocytes retrieved, duration of infertility, 
previous unsuccessful ART, percentage primary infertility, percentage tubal 
infertility); treatment characteristics (country, ICSI (all/some vs no ICSI ), number of 
embryos transferred, single or multiple cycle, pregnancy verification (pregnancy test 
vs ultrasound scan), and study characteristics (date; design (prospective or 
retrospective). 
 
Risk of bias: study quality 
Newcastle-Ottawa Scale (NOS) [25] was used to assess the quality of cohort studies 
in the meta-analysis. Each paper was independently assessed by SP and OvdA and 
cross checked with each other to reach 100% consensus through discussion. The 
scale awarded a maximum of nine stars to each study: four stars for the adequate 
selection of participants, two stars for comparability of pregnancy/live birth and no 
pregnancy/live birth groups, and three stars for the adequate ascertainment of the 
exposure in groups. We defined studies of high quality as those that scored seven-
nine stars on the Newcastle-Ottawa scale; studies of medium quality scored five-six 
stars and studies of low quality of scoring four or less stars.  
 
 
 
Data analyses 
Data were analysed using Comprehensive Meta-Analysis [26].  For BMI and lifestyle 
analysis, data were converted to odds ratios for pregnancy or live birth. For all 
studies, a weighted effect size was calculated using random effects models.  
 
Sensitivity analyses were conducted to examine whether effects were robust under 
different methodological assumptions: 1) live birth and pregnancy data are included; 
2) pregnancy ultrasound scan results and pregnancy test results are used; 3) results 
were from a single cycle; 4) IVF, ICSI or combined IVF/ICSI treatments are used: 5) 
prospective designs; 6) high quality studies were included; and 7) Studies were 
recent (published within the last 7 years -2010- was considered as recent).   
 
We quantified heterogeneity in study effect sizes using the I2 statistic.  If significant 
heterogeneity was found and more than 10 studies (as previously recommended 
[27]) provided data on putative moderating variables, the impact of seven factors 
which have been found to be associated with fertility treatment outcomes was tested 
[28]. Moderator analyses using 1) meta-regression for average age of the women 
sampled, average BMI of sample, percentage of smokers in sample, embryos 
transferred, and oocytes retrieved, and percentage of patients with primary infertility,  
tubal infertility and average duration of infertility (years) and 2) between group 
analysis comparing first time ART users vs previous unsuccessful users.  
 
We tested for the presence of publication bias by examining funnel plots for evidence 
of asymmetry, using Duval and Tweedie’s trim and fill method to impute studies 
where evidence of asymmetry was present.  We tested for the significance of these 
effects using Egger’s t-test. 
 
 
 
Results 
Search Results 
See PRISMA flow chart (Fig 1) for searches resulting in 77 included studies.  
 
Study characteristics 
Of the 77 studies included; 47 investigated BMI (table 1), 28 smoking (table 2), and 
two alcohol consumption (table 3), totalling data from 60370 patients (and 7585 
cycles). Sample sizes were modest to large, retrospective (n=50) and involved IVF 
treatment only (n=27) or with ICSI (n=47). 
 
Study quality: Most BMI studies were rated as high quality (n=10) or medium (n=36). 
Publication date varied considerably; with 27 studies published during and after 
2010. Most studies met cut off values for BMI WHO classifications (n=35). Live birth 
outcome data was reported for 20 studies.  
 
Most smoking studies were rated high quality (n=7) or medium quality (n=17) and 
were published before 2010 (n=18). Smoking status was typically self-reported and 
based on number of cigarettes smoked each day. However, four studies used 
physiological tests to detect smoking (cotinine or Rhodanide concentrations). Live 
birth outcome data was reported for 10 studies (see table 2).  
 
For alcohol studies, Table 3 shows that Matalliotakis et al [88] was rated as high 
quality and published before 2010, did not record units of alcohol drunk and reported 
pregnancy data. Whereas, Rossi et al. [101] was rated as medium quality and 
 
 
published after 2010. Alcohol drinkers were defined as patients who drank >50g of 
alcohol per week and used live birth outcomes.   
 
BMI  
 Main analysis for BMI <=24.9 and patients whose BMI was >=25: Forty 
seven studies allowed for a comparison between patients with a BMI <=24.9 
and >=25 [29-75]. Patients with a BMI <=24.9 were significantly more likely to 
achieve LB or pregnancy than with a BMI >=25 OR=1.219 (95% CI:1.128-1.319, 
z=4.971, p<001). Heterogeneity was significant (I2=53.779%, p=0.001). See figure 2 
for forest plot.  There was no moderating role of age, the number of embryos 
transferred, number of oocytes retrieved, duration of infertility and tubal infertility, 
ART naïve vs previous ART use. There was insufficient data for smoking and 
primary infertility.  
Sensitivity analysis: The effect of BMI with pregnancy or live birth data, 
single cycle, combination of IVF and ICSI, prospective design, BMI data collected 
before start of treatment, high quality and recent studies was significant and robust 
under different methodological assumptions. See Table 4 for further details.  
Analysis of normal weight versus overweight patients: Additional analysis 
using 22 studies of normal weight patients (19-24.9 BMI) and overweight patients 
(25-29.9 BMI) were compared [29-30, 32, 34-35, 41, 43, 45, 48, 49, 54, 55-57, 60, 
62-64, 70-72, 74]. Normal weight patients were significantly more likely to achieve a 
LB or pregnancy than overweight patients OR=1.168 (95% CI:1.061-1.286, z=3.159, 
p<002). There was significant heterogeneity (I2<48.589%, p=0.006). The forest plot 
of these additional BMI data and sensitivity is not presented but available upon 
request.  
 
 
Analysis of overweight versus obese patients: Overweight patients (25-
29.9 BMI) were also compared to obese patients (30-34.9 BMI) in nine studies [41, 
48, 55, 60, 63, 70-2, 74]. Overweight patients were not significantly different in 
treatment outcome than obese patients OR=1.219 (95% CI:0.965-1.540; z=1.662: 
p=.097). There was significant heterogeneity (I2=60.848; p=0.009). 
 
Smoking 
 Main analysis: Pregnancy and live birth outcomes Twenty eight studies 
were included in the meta-analyses [39, 76-100]. Non-smokers were significantly 
more likely to achieve a LB or pregnancy than smokers OR=1.457 (95% CI:1.228-
1.727, z=4.324, p<0.001). Heterogeneity was moderate (I2=51.883; p=0.001). See 
figure 3 for a forest plot for the positive effect of not smoking on outcomes. There 
was a significant moderating effect of number of embryos transferred; non-smokers’ 
relative odds of pregnancy or live birth increased as more embryos were transferred 
ln(OR) = -0.791 + 0.527(number of embryos transferred) F(1,10) = 9.39, p = 0.01. 
Although the number of studies were less than 10, analysis revealed a trend that the 
benefits of non-smoking decreases with higher BMI ln(OR)=2.279+ -0.086, Q(1,8 
=9.637, p=0.001). Similarly there was a trend using  studies with a higher number of 
women experiencing primary infertility, that the benefits of not smoking were less 
evident ln(OR)=2.404 -2.928(% of women with primary infertility), F(1,7) =6.57, p = 
0.037. Effect sizes were not significantly moderated by average female age, number 
of oocytes retrieved, first or multiple ART users, tubal cause and duration of 
infertility.  
Sensitivity analysis: The evidence for smoking was consistent under 
different methodological conditions (see table 4). 
 
 
 
Alcohol 
 Main analysis: Pregnancy and live birth outcomes: Two studies were 
available for the alcohol analyses [88, 101]. There was no significant effect of alcohol 
consumption on ART outcome OR=1.072 (95% CI: 0.630-1.822, z=0.256, p=0.798). 
Heterogeneity within this analysis was moderate but non-significant (I2=61.673%, 
p=0.106). There were too few studies to investigate moderator effects or conduct 
sensitivity analyses. 
 
Publication bias analyses 
There was evidence of publication bias in BMI data for <=24.9 vs>=25 and smoking 
data. Regarding BMI, trim and fill analyses suggested 8 studies were needed for the 
funnel plot to be symmetrical and Egger’s meta regression intercept was significant 
(t(45) = 0.863, 95% CI:0.0231.703 p=0.04). This was also true for the smoking 
analysis. Trim and fill analysis revealed 6 studies were needed for a symmetrical 
funnel plot. However, Egger’s meta-regression intercept was not significant (t(7) = 
0.674, 95% CI:-0.201-1.549 p=0.125). Publication bias analysis was not conducted 
on the alcohol use studies due to the small number of papers available. 
 
Discussion 
The aims of these meta-analyses were to examine whether lifestyle factors predict 
ART treatment success for female patients and whether life style and BMI factors 
moderate each other. This large, comprehensive meta-analysis found consistent 
evidence that being overweight/obese and smoking decreases the odds of achieving 
positive ART outcomes, confirming some meta-analyses [8, 13]. The research 
evidence for alcohol shows this is not a reliable predictor for ART success or failure, 
 
 
although the number of studies investigating the effect of alcohol consumption and 
ART outcomes remains limited.  
 
Critical discussion 
Heterogeneity for the BMI and smoking data were significant. Sensitivity analyses for 
BMI revealed no moderating effect of other variables. However, number of embryos 
transferred moderated smoking and there was a trend (using less than 10 studies) 
that primary infertility and high BMI significantly moderated the effects of smoking on 
ART outcomes. So, a patient who did not smoke, will not see any benefits of not 
smoking on her ART outcomes if she has a BMI over 25. However, this data must be 
interpreted with caution because of the small number of studies and clearly more 
research is necessary. However, this trend is consistent with previous research 
which has demonstrated the associations between smoking and BMI [20].   
 
A serious shortcoming is the lack of research into the effects of alcohol on ART 
outcomes. Likewise, Nicolau et al., [19] reported a significant effect (OR 0.84), and 
also only included two studies.  The lack of research into alcohol intake and ART 
outcomes is surprising as the harmful effects of binge or heavy drinking on 
pregnancy are well known [102] and drinking alcohol is common and increasing in 
most countries. For example, in the UK it is estimated that 68% of men and 54% of 
women drink alcohol [103] and The National Institute for Health and Clinical 
Excellence advises women who are pregnant or trying to conceive to avoid drinking 
alcohol [102]. More research is urgently needed to investigate the effect alcohol has 
on ART outcomes, particularly as this information is important for patients and 
clinicians. 
 
 
 
Studies that have measured alcohol and smoking relied heavily on self-disclosure 
from patients, although a few used independent, physiological tests to help confirm 
smoking status based on concentrations of cotinine or Rhodanide [e.g., 83, 86] ]. 
Although ART patients are often advised to stop smoking, reliance on self-reported 
smoking status was underestimated by 25% in a study of pregnant women. [104]. It 
is therefore possible that the data used to calculate pooled effect sizes 
underestimate the effects of smoking and possibly alcohol intake on ART outcomes.  
 
Finally, there was some evidence of a tendency for small studies with high variance 
to be published more often when they showed an effect for BMI or smoking, 
suggesting that the ‘file drawer problem’ might bias the published literature on these 
topics. Our meta-regression analyses were also based upon published averages of 
patient characteristics such as age or number of oocytes retrieved. It should be 
noted that these results may be different to (and less reliable) than individual patient 
data because of the potential for misleading conclusions and aggregation bias [105]. 
There are also problems with consistency among definition and classification of 
study variables. For example, many BMI studies did not have cut off values or they 
were varied and did not follow WHO recommendations for classifications which 
created difficulties in combining study results and comparing BMI groups. 
Consequently, some studies were excluded from the quantitative synthesis and the 
meta-analysis lost some precision because a few studies were combined to make 
full use of all the available data. However, despite these methodological 
shortcomings in the extracted data, there was limited statistical heterogeneity, 
suggesting BMI study results are valid and consistent with previous meta-analyses.  
 
 
 
The conclusions of this meta-analysis are that lifestyle factors that include BMI and 
smoking are contributing factors to poorer ART outcomes. More research is 
warranted to investigate the moderating role of psychological variables on lifestyle 
factors including obesity and smoking.  
 
Current knowledge on the subject 
 Research evidence for the effect of BMI on ART outcomes are often 
inconsistent. 
 Smoking has consistently been found to be detrimental to fertility outcomes 
but  the effects of alcohol on ART outcomes is inconclusive.  
 Further, there is a need to investigate whether life style and BMI factors 
moderate each other on ART outcomes. 
 
What this study adds 
 This large, comprehensive meta-analysis of published studies found 
consistent evidence that being overweight/obese and smoking significantly 
decreases the odds of achieving positive ART outcomes. 
 The effects of alcohol on ART outcomes were not significant.  
 Smoking is moderated by number of embryos transferred and there was some 
data to suggest primary infertility and high BMI was moderated by smoking.  
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Table 1: Study characteristics of body mass index (BMI) studies 
Authors Variable/ 
classification  
Time of 
assessment 
Outcome & 
assessment of 
outcome 
Design Sample 
Size 
Treatment Cycle 
(single 
or 
multiple) 
Newcastle-Ottawa 
Quality Score 
1. Akpinar et 
al 2014 
18.5-24.9 BMI 
25-29.9 BMI 
30-34.5 BMI 
 
Timing not 
specified 
P 
HCG test 
Retrospective 272 ICSI Multiple Selection *** 
Comparability  
Outcome ** 
2. Bellver et 
al 2010 
20-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Before 
stimulation 
LB 
Ultrasound scan 
Retrospective 4227 ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
3. Bu et al 
2013 
18.5-24 BMI 
>=24 BMI 
 
Timing not 
specified 
P 
Ultrasound scan 
 
Retrospective 688 IVF, ICSI Single Selection *** 
Comparability  
Outcome *** 
 
4. Caillon et 
al 2015 
18.5-24.9 BMI 
>=25 BMI 
 
Timing not 
specified 
LB 
Not specified 
Retrospective 558 IVF, ICSI Single Selection *** 
Comparability  
Outcome *** 
 
5. Dechaud et <20 BMI 
>=20-<25 BMI 
>=25-<30 BMI 
Initial 
consultatio
n 
P 
12 weeks 
gestation 
Retrospective 573 IVF, ICSI Multiple Selection *** 
Comparability  
 
 
al 2006  >=30 BMI (pregnancy  
assessment 
unspecified ) 
Outcome *** 
 
6. Dokras et 
al 2006 
<25 BMI 
25-29.9 BMI 
30-39.9 BMI 
>=40 BMI 
Initial 
consultatio
n 
LB 
Delivery after 20 
weeks gestation 
Retrospective 1293 IVF, ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
7. Esinler et 
al 2008  
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Before 
treatment 
P 
Ultrasound scan 
Retrospective 775 ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
8. Farhi et al 
2010  
<=25 BMI 
>25 BMI 
Before 
treatment 
LB 
(not specified) 
Retrospective 233 IVF, ICSI Single Selection *** 
Comparability  
Outcome *** 
 
9. Fedorcsake
t al 2004  
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Initial 
consultatio
n 
LB 
(not specified) 
Retrospective 2660 IVF, ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
10. Hill et al 
2011 
<=25 BMI 
>25 BMI 
<30 BMI 
>=30 
Timing not 
specified 
P 
Ultrasound scan 
Prospective 117 IVF Single Selection *** 
Comparability  
Outcome *** 
 
 
 
11. Huang et al 
2014 
<24 BMI 
>=24 BMI 
Timing not 
specified 
LB 
Born and 
survive more 
than 1 month 
Retrospective 256 IVF, ICSI Single Selection *** 
Comparability  
Outcome *** 
 
12. Inal et al 
2016 
<25 BMI 
>=25 BMI 
Timing not 
specified 
P 
Not specified 
Prospective 120 IVF Single Selection *** 
Comparability  
Outcome * 
 
13. Kalem et al 
2016 
18-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Timing not 
specified 
P 
Ultrasound scan 
Retrospective 653 IVF Single Selection *** 
Comparability  
Outcome *** 
 
14. Kilic et al 
2010  
18-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Timing not 
specified 
P 
Ultrasound scan 
Retrospective 1970 IVF Single Selection *** 
Comparability * 
Outcome *** 
 
15. Ku et al 
2006  
<24 BMI 
>=24 BMI 
Timing not 
specified 
P 
Ultrasound scan 
Retrospective 223 IVF, ICSI Multiple Selection ** 
Comparability  
Outcome *** 
 
 
 
16. Lashen et 
al 1999  
<19 BMI 
20-24 BMI 
>27.9 BMI 
Timing not 
specified 
P 
(not specified) 
Retrospective, 
case control 
333 IVF Single Selection *** 
Comparability  
Outcome ** 
 
17. Li et al 
2010  
<18.5 BMI 
>=18.5-23.9 
BMI 
>=24 BMI 
Before 
treatment 
LB 
(not specified) 
Retrospective 1107 IVF, ICSI Single Selection *** 
Comparability  
Outcome *** 
 
18. Lintsen et 
al 2005  
<20 BMI 
20-25 BMI 
25-27 BMI 
>=27 BMI 
Initial 
consultatio
n 
LB 
Delivery 
Retrospective 8457 IVF Single Selection *** 
Comparability  
Outcome *** 
 
19. Loveland 
et al 2001  
<=25 BMI 
>25 BMI 
Timing not 
specified 
P 
Delivered or >20 
weeks 
pregnancy 
(ultrasound 
scan) 
Retrospective 139 IVF Multiple Selection *** 
Comparability  
Outcome *** 
 
20. Maheshwa
ri et al 
2009  
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
30-34.5 BMI 
>=35 BMI 
Within 3 
months of 
commencin
g a cycle 
LB 
Delivery 
Retrospective 1756 IVF,ICSI Single Selection *** 
Comparability  
Outcome *** 
 
21. Marci et al 20-25 BMI 
>25 BMI 
Timing not 
specified 
P 
Ultrasound scan 
Prospective 463  IVF,ICSI Single Selection *** 
 
 
2012  Comparability  
Outcome *** 
 
22. Martinuzzi 
et al 2008  
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Initial 
consultatio
n 
P 
Ultrasound scan 
Retrospective 417 IVF,ICSI Single Selection *** 
Comparability  
Outcome *** 
 
23. Matalliotak
is et al 
2008a  
<=24 BMI 
>24 BMI 
Before 
treatment 
LB 
Delivery 
Retrospective 278 IVF,ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
24. Metwally 
et al 2007b  
19-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Timing not 
specified 
P 
Ultrasound scan 
Retrospective 426 IVF, ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
25. Moini et al 
2008  
<20-25 BMI 
25-<=30 BMI 
>30 BMI 
Timing not 
specified 
P  
Ultrasound 
Prospective 287 IVF, ICSI Single Selection **** 
Comparability  
Outcome *** 
 
26. Orvieto et 
al 2009 
<=25 BMI 
>25 BMI 
Timing not 
specified 
P 
Ultrasound scan 
Retrospective 59 IVF Multiple Selection *** 
Comparability ** 
 
 
Outcome *** 
 
27. Ozekinci et 
al 2015 
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
 
Timing not 
specified 
P 
Ultrasound scan 
Retrospective 298 IVF, ICSI Single Selection *** 
Comparability  
Outcome *** 
 
28. Ozgun et al 
2009  
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
30-35.9 BMI 
>=36 BMI 
Before 
ovulation 
induction 
P 
Ultrasound scan 
Prospective 604 ICSI Single Selection **** 
Comparability  
Outcome *** 
 
29. Petanovski 
et al 2011 
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
 
Timing not 
specified 
LB 
Delivery 
Retrospective 920 IVF Single Selection *** 
Comparability  
Outcome *** 
 
30. Pinborg et 
al 2011  
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Before 
treatment 
LB 
Delivery 
Prospective 487 IVF,ICSI,FE
T 
Multiple Selection **** 
Comparability  
Outcome *** 
 
31. Rabinson 
et al 2008 
<25 BMI 
>=25 BMI 
Timing not 
specified 
P 
Not specified 
Retrospective 799 
cycles  
IVF Multiple Selection *** 
Comparability  
Outcome ** 
 
 
 
32. Ramezanza
deh et al 
2012  
<25 BMI 
>=25 BMI 
Day 3 of 
spontaneou
s menstrual 
cycle 
 
P 
Ultrasound scan 
Prospective 236 IVF,ICSI Unclear Selection **** 
Comparability  
Outcome *** 
 
33. Rittenberg 
et al 2011 
18.5-24.9 BMI 
>=25 BMI 
 
Within one 
month of 
starting 
treatment 
LB 
Not specified 
Prospective 413 IVF, ICSI Multiple Selection **** 
Comparability  
Outcome *** 
 
34. Salha et al 
2001  
18-25 BMI 
>=26 BMI 
Timing not 
specified 
P 
Ultrasound scan 
Prospective 100 IVF Single Selection *** 
Comparability * 
Outcome *** 
 
35. Sathya et 
al 2010  
<25 BMI 
25-30 BMI 
>30 BMI 
Timing not 
specified 
P 
Not specified 
Retrospective 308 IVF,ICSI Unclear Selection *** 
Comparability  
Outcome ** 
 
36. Schliep et 
al 2014 
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
30-34.9 BMI  
>=35 BMI 
Initial 
consultatio
n 
LB 
Delivery 
Prospective 721 IVF Single Selection **** 
Comparability  
Outcome *** 
 
 
 
37. Setti et al 
2012  
<19 BMI 
19-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Timing not 
specified 
P 
Not specified 
Retrospective 1105  IVF,ICSI Single Selection *** 
Comparability  
Outcome ** 
 
38. Shalom-
Paz et al 
2011  
<20 BMI 
20-24 BMI 
25-29 BMI 
30-34 BMI 
>=35 BMI 
Timing not 
specified 
LB 
Delivery  
Retrospective 113 IVF, ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
39. Singh et al 
2012  
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Timing not 
specified 
P 
Not specified 
Retrospective 316 IVF,ICSI Multiple Selection *** 
Comparability  
Outcome ** 
 
40. Sneed et al 
2008  
<18.5 BMI 
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
Timing not 
specified 
LB 
Not specified 
Retrospective 1273 IVF Single Selection *** 
Comparability  
Outcome *** 
 
41. Van 
Swieten et 
al 2005  
BMI 
<25 BMI 
25-30 BMI 
>30 BMI 
Before 
down 
regulation 
P 
HCG test 
Prospective 162 IVF, ICSI Multiple Selection *** 
Comparability  
Outcome ** 
 
42. Vilarino et <25 BMI 
>=25 BMI 
Timing not 
specified 
LB 
Foetus born 
Retrospective 191 IVF, ICSI Multiple Selection *** 
 
 
al 2011  alive beyond 
22nd week 
pregnancy 
Comparability  
Outcome ** 
 
43. Vural et al 
2016 
<25 BMI 
25-30 BMI 
>=30 BMI 
Timing not 
specified 
P 
Ultrasound 
Retrospective 780 IVF Unclear Selection *** 
Comparability  
Outcome *** 
 
44. Wang et al 
2000  
<20 BMI 
20-24.9 BMI 
25-29.9 BMI 
30-34.9 BMI 
>=35 BMI 
Timing not 
specified 
P 
Ultrasound 
Retrospective 3586 IVF,ICSI,GI
FT 
Multiple Selection *** 
Comparability  
Outcome *** 
 
45. Wittemer 
et al 2000  
<20 BMI 
>=20-25 BMI 
>=25 BMI 
Timing not 
specified 
LB 
Delivery 
Retrospective 398 IVF, ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
46. Zander-Fox 
et al 2012  
18.5-24.9 BMI 
25-29.9 BMI 
30-34.9 BMI 
35-39.9 BMI 
>=40 BMI 
Before 
treatment 
LB 
Delivery 
Retrospective 2057 
cycles 
IVF,ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
47. Zhang et al 
2010  
18.5-24.9 BMI 
25-29.9 BMI 
>=30 BMI 
30-60 days 
before cycle 
LB 
Not specified 
Retrospective 2628 IVF, ICSI Single Selection *** 
Comparability  
 
 
Outcome *** 
 
Note: ART = Assisted reproductive technologies; FET = Frozen embryo transfers; GIFT = Gamete intra-fallopian transfer; ICSI = intracytoplasmic sperm injection; IVT = in vitro fertilisation; 
LB = live birth outcome data; P= pregnancy outcome data; ZIFT = zygote intrafallopian transfer. The sample size refers to data that is extracted from the papers and used in the meta-
analysis. 
 
 
 
Table 2: Study characteristics of Smoking studies 
Authors Variable/ 
classification  
Time of 
assessment 
Outcome & 
assessment 
of outcome 
Design Sample 
Size 
Treatment Cycle 
(single or 
multiple) 
Newcastle-Ottawa 
Quality Score 
1. Al-Saleh et 
al 2010  
Smokers vs Non-
smokers (self 
report)  
Timing not 
specified 
P 
Ultrasound 
scan 
 
Prospective 619 IVF,ICSI Single Selection **** 
Comparability * 
Outcome *** 
2. Ben-
Haroush et 
al 2011  
Smokers vs Non-
smokers  
(self report) 
Data 
collected 
post-
treatment 
on their 
smoking 
status 
during 
treatment 
LB 
Not 
specified 
Retrospective 237 IVF,ICSI Single Selection ** 
Comparability  
Outcome *** 
 
3. Chung et al 
1997  
Smokers = >1 
cigarettes a day 
Non smokers = 0 
cigarettes 
(self report) 
Data 
collected 
post-
treatment 
on their 
smoking 
status 
during 
treatment 
LB 
Not 
specified 
Retrospective 85 GIFT Single Selection *** 
Comparability  
Outcome *** 
 
4. Crha et al 
2001  
Smokers = >1 
cigarettes a day 
Non smokers = 0 
cigarettes 
Before 
stimulation 
P 
Ultrasound 
Prospective 159 IVF Single Selection *** 
Comparability  
Outcome *** 
 
 
(self report)  
5. Dessolle et 
al  2011  
Smokers vs Non-
smokers  
(self report) 
Timing not 
specified 
LB 
Delivery of 
healthy 
term 
singleton 
Prospective 872 IVF, ICSI Single Selection **** 
Comparability  
Outcome *** 
 
6. El-Nemr et 
al 1998  
Smokers >1 
cigarettes a day 
Non-smokers 0 
cigarettes a day 
(self report) 
Initial 
consultation 
P 
Ultrasound 
scan 
Retrospective 173 IVF Single Selection *** 
Comparability  
Outcome *** 
 
7. Freour et al 
2010  
Smokers vs Non-
smokers  
(self report) 
Initial 
consultation 
P 
Ultrasound 
scan 
Prospective 384 IVF,ICSI multiple Selection **** 
Comparability * 
Outcome *** 
 
8. Freour et al 
2012  
Smokers vs Non-
smokers  
(self report) 
Initial 
consultation 
LB 
Not 
specified 
Prospective 277 IVF Single Selection **** 
Comparability  
Outcome *** 
 
9. Freour et al 
2013 
Smokers vs Non-
smokers  
(self report) 
Initial 
consultation 
P 
Ultrasound 
scan 
Retrospective 135 IVF, ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
 
 
10. Fuentes et al 
2010  
Smokers vs non-
smokers 
(self-report) and 
assessment-
smokers who had 
cotinine 
concentrations 
and non-smokers 
who did not) 
Before 
oocyte 
retrieval 
LB 
(not 
specified) 
Prospective 166 IVF,ICSI Single Selection *** 
Comparability  
Outcome *** 
 
11. Gruber et al 
2008  
Smokers vs Non-
smokers  
(self report) 
Initial 
consultation 
P 
Ultrasound 
scan 
Retrospective 130 ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
12. Hannoun et 
al 2010 
Smokers vs Non-
smokers 
(self report) 
Before 
oocyte 
retrieval 
P 
Ultrasound 
scan 
 
Prospective 246 
 
IVF,GIFT Single Selection ** 
Comparability  
Outcome ** 
 
13. Harrison et 
al 1990  
Smokers >1 
cigarettes a day 
Non-smokers 0 
cigarettes a day 
(self report) 
Initial 
consultation 
P 
Not 
specified 
Prospective 650 IVF, ICSI Single Selection **** 
Comparability  
Outcome * 
 
14. Hughes et al 
1994  
Smokers vs non-
smokers (self-
report  and 
assessment-
smokers who had 
Self report 
before and 
cotinine 
testing 
during 
P 
Ultrasound 
scan 
Prospective 316 IVF Multiple Selection **** 
Comparability  
Outcome *** 
 
 
cotinine 
concentrations 
and non-smokers 
who did not) 
treatment  
15. Joesbury et 
al 1998  
Smokers vs Non-
smokers  
(self report) 
Initial 
consultation 
LB 
Alive one 
month post 
delivery 
Retrospective 385 IVF,ICSI Multiple Selection *** 
Comparability  
Outcome *** 
 
16. Lintsen et al 
2005  
Smokers >1 
cigarettes a day 
Non-smokers 0 
cigarettes a day 
(self report) 
Before 
oocyte 
retrieval 
LB 
Delivery 
Retrospective 8457 IVF Single Selection *** 
Comparability  
Outcome *** 
 
17. Matalliotakis 
et al 2008b  
Smokers vs Non-
smokers  
(self report) 
Before 
treatment 
P 
Ultrasound 
scan 
Retrospective 297 IVF,ICSI Multiple Selection *** 
Comparability * 
Outcome *** 
 
18. Maximovich 
et al 1995 
Smokers vs Non-
smokers  
(self report) 
Initial 
consultation 
P 
Not 
specified 
Retrospective 253 IVF Multiple Selection *** 
Comparability  
Outcome *** 
 
19. Neal et al 
2008 
Smokers vs Non-
smokers  
(self report) 
Initial 
consultation 
P 
Not 
specified 
Prospective 29 IVF Unclear Selection * 
Comparability  
Outcome ** 
 
 
 
20. Pattinson et 
al 1991  
Smokers >1 
cigarettes a day 
Non-smokers 0 
cigarettes a day 
(self report) 
Initial 
consultation 
LB 
Delivery 
Retrospective 447 IVF Single Selection *** 
Comparability  
Outcome *** 
 
21. Petanovski 
et al 2012  
Smokers >1 
cigarettes a day 
Non-smokers 0 
cigarettes a day 
(self report) 
Before 
oocyte 
retrieval 
LB 
Delivery 
Prospective 879 COS,ICSI Single Selection *** 
Comparability  
Outcome *** 
 
22. Sharara et al 
1994  
Smokers vs Non-
smokers  
(self report) 
Timing not 
specified 
LB 
Delivery 
Retrospective 102 IVF Unclear Selection ** 
Comparability  
Outcome *** 
 
23. Sterzik et al 
1996  
Smokers vs non-
smokers (self 
report and -
cotinine 
concentrations >50 
ng/mL  and non-
smokers cotinine 
concentrations 
<=20 ng/mL) 
Self report 
before and 
cotinine 
testing 
during 
treatment 
P 
Ultrasound 
scan 
Prospective 197 IVF Single Selection **** 
Comparability  
Outcome *** 
 
24. Tiboni et al Smokers >1 
cigarettes a day 
Non-smokers 0 
Timing not 
specified 
P 
Ultrasound 
scan  
Prospective 60 IVF,ICSI Unclear Selection *** 
Comparability  
 
 
2004  cigarettes a day 
(self report) 
Outcome *** 
 
25. Trapp et al 
1986 
Smokers vs non-
smokers(self-
report  and 
assessment of SCN 
concentrations 
(Rhodanide) 
During 
treatment 
P 
Pregnancy 
test 
Prospective 114 IVF Unclear Selection ** 
Comparability  
Outcome ** 
 
26. Van Voorhis 
et al 1996 
Smokers vs Non-
smokers  
(self report) 
Timing not 
specified 
P 
Ultrasound 
scan  
Retrospective 499 IVF, GIFT 
and 
ZIFT 
Single Selection *** 
Comparability  
Outcome *** 
 
27. Weigert et 
al 1999  
Smokers >1 
cigarettes a day 
Non-smokers 0 
cigarettes a day 
(self report) 
Before 
stimulation 
P 
Not 
specified 
Retrospective 834 IVF Unclear Selection ** 
Comparability  
Outcome ** 
 
28. Wright et al 
2006  
Smokers >1 
cigarettes a day 
Non-smokers 0 
cigarettes a day 
(self report) 
Initial 
consultation 
P 
Ultrasound 
scan  
Retrospective 389 IVF, ICSI Single Selection ** 
Comparability  
Outcome *** 
 
Note: ART = Assisted reproductive technologies; GIFT = Gamete intra-fallopian transfer; ICSI = intracytoplasmic sperm injection; IVT = in vitro fertilisation; LB = live birth 
outcome data; ZIFT = zygote intrafallopian transfer. The sample size refers to data that is extracted from the papers and used in the meta-analysis. 
 
 
 
 
 
 
Table 3: Study characteristics of Alcohol consumption studies  
Authors Variable/ 
classification  
Time of 
assessment 
Outcome & 
assessment 
of outcome 
Design Sample 
Size 
Treatment Cycle 
(single or 
multiple) 
Newcastle-Ottawa 
Quality Score 
1. Matalliotakis 
et al 2008b  
Alcohol 
consumption 
vs non-
alcohol 
consumption  
(self report) 
Before 
treatment 
P 
Ultrasound 
scan 
Retrospective 297 IVF,ICSI Multiple Selection *** 
Comparability * 
Outcome *** 
 
2. Rossi et al 
2011  
Alcohol 
drinkers >50 
g (> 4 drinks 
per week) vs 
non-alcohol 
drinkers 0-
49g(<4 
drinkers per 
week) 
(self report) 
Before 
treatment 
LB 
Delivery 
Prospective 4729 
cycles 
IVF Multiple Selection *** 
Comparability  
Outcome *** 
 
Note: ART = Assisted reproductive technologies; ICSI = intracytoplasmic sperm injection; IVT = in vitro fertilisation; LB = live birth outcome data; P= pregnancy outcome 
data. The sample size refers to data that is extracted from the papers and used in the meta-analysis. 
 
 
 
 
 
Table 4: Sensitivity analyses 
BMI 
 OR [95% CI OR] Heterogeneity (I2) 
Live birth only k=20 1.16 [1.07, 1.26], z=3.532, p=0.001 32.832%, p=0.078 
Pregnancy only k=27 1.286 [1.125, 1.471], z=3.675, p=0.001  62.673%, p=0.001 
Pregnancy scan only k=18  1.295 [1.117, 1.501] z=3.436, p=0.001   69.091%, p=0.001 
Single cycle only k=23 1.167 [1.061, 1.284] z=3.186, p=0.001  34.046%, p=0.057 
Only IVF k=10  1.385 [1.018, 1.885] z=2.071, p=0.038  79.358%, p=0.001 
ICSI treatments k=3 1.261 [0.914, 1.739] z=1.412, p=0.158 81.952%, p=0.004 
ICSI and IVF k=33 1.193  [1.108, 1.284] z=4.696, p<0.001 27.103%, p=0.078 
Prospective studies k=10 1.216 [0.976, 1.516] z=1.740, p=0.082  45.114%, p=0.059 
High quality studies k=10  1.284 [1.038, 1.587] z=2.305, p=0.021  72.451%, p<0.001 
Recent studies only k=27 1.212 [1.078, 1.364] z=3.204, p=0.001  62.399%, p=0.001 
SMOKING  
live birth outcomes k=10 1.510 [1.174, 1.942] z=3.206 p=0.001)  57.315%, p=0.012 
 
 
pregnancy outcomes k=18 1.444 [1.121, 1.861] z=2.843: 
p=0.004)  
51.317%, p=0.006 
pregnancy scan only k = 
13 
1.373 [1.015-1.856] z=2.058: p=0.04:  51.328%, p =0.017   
Single cycle k=17  1.623 [1.280, 2.057] z=3.998: p<0.001 65.000%, p<0.001 
IVF only k=12  1.461 [1.194-1.787] z=3.686: p<0.001)  23.208%, p =0.216 
IVF and ICSI mixed k=11: 1.430 [1.037-1.971] z=2.182: p=0.029:  62.836%, p=0.003 
Prospective studies k=14 1.711 [1.247-2.348] z=3.327: p=0.001)  66.571%, p< 0.001 
High quality study k=7) 1.416 [0.972, 2.065] z=1.811: p=0.070 67.440, p=0.005 
Recent studies only k=10 1.548 [1.124-2.132] z=2.678: p=0.007:  66.902%, p =0.001 
 
Note: There was only two studies that reported only using ICSI in the smoking analysis and no studies which used a positive pregnancy test as 
an outcome so these sensitivity analyses are not presented 
 
 
 
 
 
 
Records identified through 
database searching 
(n = 2723)
Additional records identified 
through other sources 
(n = 3)
Records after duplicates removed
(n = 2671)
Records screened
(n = 615)
Records excluded
(n = 2056)
Full-text articles 
assessed for eligibility
(n =261)
Full-text articles excluded, with 
reasons (N=184)
No reported data on maternal BMI, 
smoking or Alcohol and ART outcome 
data = 68
Adjusted data = 21
Not WHO BMI classification and 
unable to merge in datafile = 22
Not in English = 11
Multiple reports = 10
No relevant ART outcome data = 10
Secondhand smoking data only = 4
Non-smokers classification includes 
smoking = 3
Not ART treatment (e.g., IUI) or 
involved gamete donation = 6
Published protocol or intervention 
study = 7
Male and female data combined =3
Incompatible data for datafile = 10
Not relevant samples or have no 
suitable comparison group = 6
Not sufficient BMI data = 1
Letter = 1
Paper unavailable = 1
Studies included in 
qualitative synthesis
(n =  77)
Studies included in 
quantitative synthesis 
(meta-analysis)
(n = 77 ) 
 
 
 
 
Figure 1: PRISMA 2009 Flow Diagram of studies included in the lifestyle and body mass index meta-analysis 
 
  
 
 
 
 
 
 
 
 
 
 
 
